{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:20:55Z","timestamp":1764332455772},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejrad.2016.11.009","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T17:31:49Z","timestamp":1478367109000},"page":"92-98","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Metabolic response assessment with 18F-FDG-PET\/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma"],"prefix":"10.1016","volume":"86","author":[{"given":"Shingo","family":"Kanemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozo","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Funaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2016.11.009_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1753465816628800","article-title":"Malignant pleural mesothelioma: an update on diagnosis and treatment options","volume":"10","author":"Kondola","year":"2010","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization classification of tumors of the pleura: Advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0015","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5301\/tj.5000436","article-title":"Systemic approach to malignant pleural mesothelioma: what news of chemotherapy targeted agents and immunotherapy?","volume":"102","author":"Signorelli","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0025","article-title":"New therapeutic strategies for malignant pleural mesothelioma","author":"Bonelli","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thorsurg.2016.04.003","article-title":"Current treatment of mesothelioma: extrapleural pneumonectomy versus pleurectomy\/decortication","volume":"26","author":"Wolf","year":"2016","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0035","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","article-title":"Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1634\/theoncologist.12-7-850","article-title":"Multidisciplinary treatment of malignant pleural mesothelioma","volume":"12","author":"Ceresoli","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","article-title":"FDG-PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival","volume":"38","author":"Gerbaudo","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2016.11.009_bib0050","first-page":"508","article-title":"Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future","volume":"1","author":"Nowak","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/etm.2012.572","article-title":"Clinical utility of 18-fluorodeoxyglucose positron emission tomography\/computed tomography in malignant pleural mesothelioma","volume":"4","author":"Terada","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-5002(03)00292-7","article-title":"Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma","volume":"43","author":"van Klaveren","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","article-title":"Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma","volume":"67","author":"Veit-Haibach","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lungcan.2003.07.005","article-title":"Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases","volume":"43","author":"Monetti","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann.Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11604-016-0555-1","article-title":"Present and future roles of FDG-PET\/CT imaging in the management of malignant pleural mesothelioma","volume":"34","author":"Kitajima","year":"2016","journal-title":"Jpn. J. Radiol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0105","first-page":"1059","article-title":"Consensus recommendations for the use of 18F-FDG-PET as an indicator of therapeutic response in patients in National Cancer Institute Trials","volume":"47","author":"Shankar","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0110","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/JTO.0b013e318269fe21","article-title":"Optimization of response classification criteria for patients with malignant pleural mesothelioma","volume":"7","author":"Labby","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0115","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdq173","article-title":"ESMO Guidelines Working Group. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up","volume":"21","author":"Stahel","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-5002(95)00508-0","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group","volume":"14","author":"Rusch","year":"1996","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0125","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00259-015-3070-1","article-title":"Association between (1)(8)F-FDG uptake and molecular subtype of breast cancer","volume":"42","author":"Kitajima","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0130","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2016.11.009_bib0135","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jtho.2016.04.025","volume":"11","author":"Nakashima","year":"2016","journal-title":"J. Thorac Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1999.17.1.25","article-title":"Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study","volume":"17","author":"Byrne","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ctrv.2007.07.012","article-title":"Assessment of tumor response in malignant pleural mesothelioma","volume":"33","author":"Ceresoli","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12199-007-0016-7","article-title":"Current therapies for malignant pleural mesothelioma","volume":"13","author":"Nakano","year":"2008","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11748-014-0389-7","article-title":"Extrapleural pneumonectomy or pleurectomy\/decortication for malignant pleural mesothelioma","volume":"62","author":"Hasegawa","year":"2014","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejrad.2016.11.009_bib0160","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T23:26:45Z","timestamp":1536276405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X16303588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"alternative-id":["S0720048X16303588"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.11.009","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic response assessment with 18F-FDG-PET\/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}